A Novel MRI Marker for Prostate Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1, 2008, Pages 5-8

  Frank, Steven J ^a   Stafford, R Jason ^a   Bankson, James A ^a   Li, Chun ^a   Swanson, David A ^a   Kudchadker, Rajat J ^a   Martirosyan, Karen S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Brachytherapy; Cobalt; Contrast agent marker; Magnetic resonance imaging; Prostate cancer

Indexed keywords

COBALT COMPOUNDS; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; ONCOLOGY; SUPERPARAMAGNETISM; TITANIUM COMPOUNDS;

BRACHYTHERAPY; CONTRAST AGENT MARKER; PROSTATE CANCER; SEQUENCING TECHNIQUES;

RADIOTHERAPY;

ACRYLIC ACID; AGAROSE; COBALT CHLORIDE; CONTRAST MEDIUM; GLASS; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; STOICHIOMETRY;

ACRYLATES; ANIMALS; BRACHYTHERAPY; COBALT; CONTRAST MEDIA; DOGS; GLASS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MALE; NITRATES; PHANTOMS, IMAGING; PROSTATIC NEOPLASMS;

EID: 41749091611     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.01.028     Document Type: Article

References (10)

1. Frank S.J., Pisters L.L., Davis J., et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177 (2007) 2151-2156
2. Merrick G.S., Butler W.M., Wallner K.E., et al. Variability of prostate brachytherapy pre-implant dosimetry: A multi-institutional analysis. Brachytherapy 4 (2005) 241-251
3. Stock R.G., and Stone N.N. Importance of post-implant dosimetry in permanent prostate brachytherapy. Eur Urol 41 (2002) 434-439
4. Han B.H., Wallner K., Merrick G., et al. The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters. Med Phys 30 (2003) 1096-1102
5. Roy J.N., Wallner K.E., Harrington P.J., et al. A CT-based evaluation method for permanent implants: Application to prostate. Int J Radiat Oncol Biol Phys 26 (1993) 163-169
6. McLaughlin P.W., Troyer S., Berri S., et al. Functional anatomy of the prostate: Implications for treatment planning. Int J Radiat Oncol Biol Phys 63 (2005) 479-491
7. Crook J., Milosevic M., Catton P., et al. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy 1 (2002) 66-73
8. Roberson P.L., McLaughlin P.W., Narayana V., et al. Use and uncertainties of mutual information for computed tomography/magnetic resonance (CT/MR) registration post permanent implant of the prostate. Med Phys 32 (2005) 473-482
9. Shetty A.M., Stafford R.J., Elliott A.M., et al. Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model. J Magn Reson Imaging 26 (2007) 1672-1677
10. Frank S.J., Grimm P.D., Sylvester J.E., et al. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States. Brachytherapy 6 (2007) 2-8